The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Chloro-2-((2S,4S)-4-fluoro-1-(9H-purin-6-yl)pyrrolidin-2-yl)-3-phenylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one ID: ALA4548876
PubChem CID: 72949203
Max Phase: Preclinical
Molecular Formula: C21H16ClFN8O
Molecular Weight: 450.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1c2c(Cl)ccn2nc([C@@H]2C[C@H](F)CN2c2ncnc3[nH]cnc23)n1-c1ccccc1
Standard InChI: InChI=1S/C21H16ClFN8O/c22-14-6-7-30-17(14)21(32)31(13-4-2-1-3-5-13)19(28-30)15-8-12(23)9-29(15)20-16-18(25-10-24-16)26-11-27-20/h1-7,10-12,15H,8-9H2,(H,24,25,26,27)/t12-,15-/m0/s1
Standard InChI Key: YKETZZCLYKIFPU-WFASDCNBSA-N
Molfile:
RDKit 2D
32 37 0 0 0 0 0 0 0 0999 V2000
24.2137 -14.7928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9258 -14.3844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9258 -13.5593 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2137 -13.1426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5017 -14.3844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5017 -13.5593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7170 -13.3043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2320 -13.9718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7170 -14.6392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6379 -13.1509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3515 -13.5673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0667 -13.1576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0696 -12.3316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3513 -11.9171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6389 -12.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6408 -14.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7259 -15.6179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.5326 -15.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9463 -15.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3950 -14.4629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1143 -16.1666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3293 -15.9088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7158 -16.4593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8859 -17.2675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2853 -16.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6772 -17.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0128 -18.2691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8284 -18.1812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9967 -17.3784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2137 -12.3176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4622 -12.5196 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.7669 -14.9916 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6 4 1 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
3 10 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
16 2 1 6
21 22 2 0
22 23 1 0
23 24 2 0
24 26 1 0
25 21 1 0
17 21 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 29 2 0
29 25 1 0
4 30 2 0
7 31 1 0
19 32 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 450.87Molecular Weight (Monoisotopic): 450.1120AlogP: 3.09#Rotatable Bonds: 3Polar Surface Area: 97.00Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.83CX Basic pKa: 3.04CX LogP: 2.55CX LogD: 2.55Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.08
References 1. Jia H, Dai G, Su W, Xiao K, Weng J, Zhang Z, Wang Q, Yuan T, Shi F, Zhang Z, Chen W, Sai Y, Wang J, Li X, Cai Y, Yu J, Ren P, Venable J, Rao T, Edwards JP, Bembenek SD.. (2019) Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors., 62 (10): [PMID:31033293 ] [10.1021/acs.jmedchem.8b02014 ]